References
- Kunkel H. G., Franklin E. C., Muller-Eberhard H. J. Studies on the isolation and characterization of the “rheumatoid factor”. J Clin Invest 1959; 38: 424–34
- Carson D. A., Chen P. P., Fox R. I., Kipps T. J., Rad-Oux V., Jirik F., Goldflen R. D., Fox R. I., Silverman G. J., Fong S. Idiotypic and genetic studies of human rheumatoid factors. Arthritis Rheum 1987; 30: 1321–5
- Avrameas S. Natural autoantibodies: from “horror autotoxicus” to “gnothi seauton”. Immunol Today 1991; 12: 154–9
- Djavad N., Bas S., Shi X., Schwager J., Jeannet M., Vischer T., Roosnek E. Maturation of rheumatoid factors by a non-auto immune mechanism. Eur J Immunol 1996; 26: 2480–6
- Padlan E. A. Anatomy of the antibody molecule. Mol Immunol 1994; 31: 169–217
- Chen C, Stenzel-Poore M. P., Rittenberg M. B. Natural auto- and polyreactive antibodies differing from antigen-induced antibodies in the H chain CDR3. J Immunol 1991; 147: 2359–67
- Harindranath N., Goldfarb I. S., Ikematsu H., Burastero S. E., Wilder R. L., Notkins A. L., Casali P. Complete sequence of the genes encoding the VH and VL regions of low- and high-affinity monoclonal IgM and IgAI rheumatoid factors produced by CD5+ B cells from a rheumatoid arthritis patient. Int Immunol 1991; 3: 865–75
- Crouzier R., Martin T., Pasquali J. L. Heavy chain variable region, light chain variable region, and heavy chain CDR3 influences on the mono- and polyreactivity and on the affinity of human monoclonal rheumatoid factors. J Immunol 1995; 154: 4526–35
- Pascual V., Victor K., Randen I., Thompson K., Steinitz M., Forre O., Fu S. M., Natvig J., Capra J. D. Nucleotide sequence analysis of rheumatoid factors and polyreactive antibodies derived from patients with rheumatoid arthritis reveals diverse use of VH and VL, gene segments and extensive variability in CDR-3. Scand J Immunol 1992; 36: 349–62
- Ermel R. W., Kenny T. P., Wong A., Solomon A., Chen P. P., Robbins D. L. Preferential utilization of a novel V lambda 3 gene in monoclonal rheumatoid factors derived from the synovial cells of rheumatoid arthritis patients. Arthritis Rheum 1994; 37: 860–8
- Youngblood K., Fruchter L., Ding G., Lopez J., Bona-Gura V., Davidson A. Rheumatoid factors from the peripheral blood of two patients with rheumatoid arthritis are genetically heterogeneous and somatically mutated. J Clin Invest 1994; 93: 852–61
- Jain R. I., Fais F., Kaplan S., Sellars B., Brooks R., Chartash E., Furie R., Hashimoto S., Chiorazzi N. Ig H and L chain variable region gene sequence analyses of twelve synovial tissue-derived B cell lines producing IgA, IgG, and IgM rheumatoid factors structure/function comparisons of antigenic specificity, V gene sequence, and Ig isotype. Autoimmunity 1995; 22: 229–43
- Hopp T. P., Woods K. R. Prediction of protein antigenic determinants from amino acid sequences. Proc Natl Acad Sci USA 1981; 78: 3824–8
- Voller A., Bidwell D., Bartlett A. Microplate enzyme immunoassays for the immunodiagnosis of virus infections. Manual of Clinical Immunoloyg, N R Rose, H. Friedman. American Society for Microbiology, Washington 1976; 506–12
- Jefferis R., Nik Jaafar M.I., Steinitz M. Immunogenic and antigenic epitopes of immunoglobulins. VIII. A monoclonal rheumatoid factor having specificity for a discontinuous epitope determined by His/Arg interchange at residue 435 of immunoglobulin G. Immunol Letters 1984; 7: 191–4
- Natvig J. B., Randen I., Thompson K., Forre O., Mage-Ed R. A., Jefferis R., Carson D. A., Tighe H., Pascual V., Victor K. D., Capra J. D. Probing of the rheumatoid factor (RF) V gene repertoire in rheumatoid arthritis (RA) by hybridoma clones. Clin Exp Rheumatol 1990; 8(Suppl 5)75–80
- Mian I. S., Bradwell A. R., Olson A. J. Structure, function and properties of antibody binding sites. J Mol Biol 1991; 217: 133–51
- Stewart A. K., Huang C, Long A. A., Stollar B. D., Schwartz R. S. VH-gene representation in autoantibodies reflects the normal human B-cell repertoire. Immunol Rev 1992; 128: 101–22